Answers are grounded in this paper and cite their sources.
Analysis reveals long-term safety and treatment effectiveness of Canakinumab in TRAPS patients, indicating its potential benefits.
Data from this interim analysis support the long-term effectiveness and safety of canakinumab for the treatment of TRAPS.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: